Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children
•Omega-3-dose adjusted to BSA strongly correlated to blood omega-3 concentrations.•Results suggest a supplementation dose of 1500 mg/m2 BSA for further studies.•The DPA increase motivated an extended ω3-index, EDD index (∑EPA,DPA,DHA). Omega-3 fatty acids have been suggested as a complement in cance...
Saved in:
Published in | Prostaglandins, leukotrienes and essential fatty acids Vol. 169; p. 102285 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Scotland
Elsevier Ltd
01.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •Omega-3-dose adjusted to BSA strongly correlated to blood omega-3 concentrations.•Results suggest a supplementation dose of 1500 mg/m2 BSA for further studies.•The DPA increase motivated an extended ω3-index, EDD index (∑EPA,DPA,DHA).
Omega-3 fatty acids have been suggested as a complement in cancer treatment, but doses are not established. We performed a dose-finding study in 33 children in remission from cancer. Participants were allocated to a body surface area (BSA) adjusted dose (mg/m2) of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (40:60), ranging 233–3448 mg/m2 daily for 90 days. Fatty acid concentration in plasma phospholipids and red blood cells were determined by GC. Supplementation was well tolerated and correlated strongly with blood ω3-fatty acid concentrations and EPA showed the highest increase. Using the ω3-index disregards docosapentaenoic acid (DPA), which increased 30–43% in our study motivating an EDD-index (∑EPA,DPA,DHA). The ratio between arachidonic acid and EPA or DHA showed negative exponential trends. Dose per BSA enabled an individualized omega-3 supplementation decreasing the variation referred to interindividual differences. Based on our results, we suggest a dose of 1500 mg/m2 BSA for further studies. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0952-3278 1532-2823 1532-2823 |
DOI: | 10.1016/j.plefa.2021.102285 |